JW Holdings has commenced the full-scale export of “WINUF Central 736-1085 ml,” a three-chamber comprehensive nutritional fluid product, to Asia Pharma LLC in Mongolia, as announced on Nov. 28.JW Holdings, overseeing JW Group’s global operations, had previously secured an exclusive supply contract f
JW Life Science is attracting attention by becoming the first Asian company to export a third-generation total parenteral nutrition (TPN) product to the European market.JW Life Science, a wholly owned subsidiary of JW Holdings, said on March 27 that Baxter, which holds global sales rights to JW Life
JW Holdings is accelerating advance into "pharmerizing" markets. “Pharmerging” is a new term which combines “pharmacy” and “emerging” and a pharmerging market means an emerging pharmaceutical market, such as Brazil and India.JW Holdings announced on May 23 that the company signed export agreements w
As domestic pharmaceutical companies have started gaining recognition of their new drug development capabilities overseas, they are expanding technology exports. As products newly-released abroad through technology exports are receiving a positive consumer response not only in emerging countries, in